Biomarin Pharmaceuticals (BMRN)
$76.50 4.77 (6.65%)
18:08 EDT BMRN Stock Quote Delayed 15 Minutes
Previous Close $76.50
Market Cap 13.52B
PE Ratio -91.07
Volume (Avg. Vol.) 1.86M
Day's Range 72.13 - 76.68
52-Week Range 71.53 - 106.74
Dividend & Yield N/A (N/A)
BMRN Stock Predictions, Articles, and Biomarin Pharmaceuticals News
- From InvestorPlace
- From the Web
We are now approaching the second half of 2019. And it may be time for a little portfolio rebalancing. Biotech stocks often move independently from the market, and these 5 are worth a look.
These takeover stocks all look like promising takeover targets at a time when M&A activity is likely to pick up.
We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after dec....
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
Biotech stocks are only as good as their pipeline. These five biotech companies are about to put out promising new drugs, with more products in the works.
BioMarin (BMRN) stock was on the rise today following positive news for its gene therapy efforts to treat severe hemophilia.
Portfolio Grader currently ranks BioMarin Pharmaceuticals (NASDAQ:BMRN) a Sell. Using Louis Navellier's investing methodology, this analytical tool researches stocks by means of fundamental and quantitative analytical tools. BMRN has maintained this ranking for 4 months.
3 Big Stock Charts for Wednesday: Twilio Inc (TWLO), BioMarin Pharmaceutical Inc. (BMRN) and Mondelez International Inc (MDLZ)
BioMarin Pharmaceutical (BMRN), Mondelez International (MDLZ) and Twilio (TWLO) are all teetering on the brink of bearish signals.
These five top biotech stocks have the seal of approval from the Street, with 'strong buy' analyst consensus ratings and big upside.
Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.
Biotechs have stabilized and offer the potential to deliver substantial returns. Here are 5 biotech stocks that fit our investment criteria
This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Wayfair Inc (W), BioMarin Pharmaceutical Inc. (BMRN) and Norwegian Cruise Line Holdings Ltd (NCLH) Are 3 of Today’s Worst Stocks
Owners of BioMarin Pharmaceutical (BMRN), Norwegian Cruise Line (NCLH) and Wayfair (W) were less than thrilled on Tuesday.
BioMarin Pharmaceutical Inc. broke from a triple-top on high volume.
Why BioMarin Pharmaceutical Inc. (BMRN), Western Digital Corp (WDC) and WhiteWave Foods Co (WWAV) Are 3 of Today’s Best Stocks
Takeover talk and improved earnings guidance made BMRN, WDC and WWAV three of Thursday's best performers.
The following stocks were moving the Manufacturing sector today.
Why American Airlines Group Inc (AAL), BioMarin Pharmaceutical Inc. (BMRN) and Cavium Inc (CAVM) Are 3 of Today’s Worst Stocks
Too bad for owners of American Airlines (AAL), BioMarin Pharmaceutical (BMRN) and Cavium (CAVM) the market doesn't do do-overs.
From Market News Video
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (BIIB), where a total of 6,128 contracts have traded so far, representing approximately 612,800 underlying shares. That amounts to about 44.8% of BIIB's average daily trading volume over the past month of 1.4 million shares..
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!